Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis

Chigusa Nakajima, Takao Mukai, Nobuya Yamaguchi, Yasunari Morimoto, Woong Ryeon Park, Masayuki Iwasaki, Ping Gao, Shiro Ono, Hiromi Fujiwara, Toshiyuki Hamaoka

Research output: Contribution to journalArticle

Abstract

We examined the effect of a monoclonal antibody (mAb) against interferon (IFN)-inducible protein 10 (IP-10)/CXCL10 on the development of experimental autoimmune encephalomyelitis (EAE) in rats induced by injecting xenogeneic brain homogenates into footpads. Treatment with neutralizing mAb against CXCL10 exacerbated EAE with increased infiltrating CD4+ cells in the central nervous system. Furthermore, the exacerbation by the mAb treatment was accompanied by less enlarged draining popliteal lymph nodes (LN) in parallel with cell number compared with those of EAE rats treated with control mAb, whereas other lymphoid organs such as the spleen and thymus were not significantly different between rats treated with anti-CXCL10 and the control mAb. Induction of gene expression of CXCL9/Mig and CXCL10 and their receptor CXCR3 was confirmed in the draining LN in EAE rats. Induction of the third CXCR3 ligand, CXCL11/I-TAC was not seen in the draining LN, whereas all three CXCR3 ligands and CXCR3 itself were markedly detected in the spinal cords following the development of EAE. These findings suggest that CXCL10 produced in the LN plays a specific inhibitory role in the development of Th1-mediated diseases such as EAE by holding sensitized and activated Th1s expressing CXCR3 in the draining LN.

Original languageEnglish (US)
Pages (from-to)1784-1791
Number of pages8
JournalEuropean Journal of Immunology
Volume32
Issue number6
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Chemokine CXCL10
Autoimmune Experimental Encephalomyelitis
Lymph Nodes
Monoclonal Antibodies
CXCR3 Receptors
Ligands
Neutralizing Antibodies
Thymus Gland
Spinal Cord
Spleen
Central Nervous System
Cell Count
Gene Expression
Brain

Keywords

  • Chemokine
  • Experimental autoimmune encephalomyelitis
  • Lymph node
  • Spleen
  • Th1

ASJC Scopus subject areas

  • Immunology

Cite this

Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis. / Nakajima, Chigusa; Mukai, Takao; Yamaguchi, Nobuya; Morimoto, Yasunari; Park, Woong Ryeon; Iwasaki, Masayuki; Gao, Ping; Ono, Shiro; Fujiwara, Hiromi; Hamaoka, Toshiyuki.

In: European Journal of Immunology, Vol. 32, No. 6, 2002, p. 1784-1791.

Research output: Contribution to journalArticle

Nakajima, C, Mukai, T, Yamaguchi, N, Morimoto, Y, Park, WR, Iwasaki, M, Gao, P, Ono, S, Fujiwara, H & Hamaoka, T 2002, 'Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis', European Journal of Immunology, vol. 32, no. 6, pp. 1784-1791. https://doi.org/10.1002/1521-4141(200206)32:6<1784::AID-IMMU1784>3.0.CO;2-R
Nakajima, Chigusa ; Mukai, Takao ; Yamaguchi, Nobuya ; Morimoto, Yasunari ; Park, Woong Ryeon ; Iwasaki, Masayuki ; Gao, Ping ; Ono, Shiro ; Fujiwara, Hiromi ; Hamaoka, Toshiyuki. / Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis. In: European Journal of Immunology. 2002 ; Vol. 32, No. 6. pp. 1784-1791.
@article{a8a1571e62ed43a89932a2087feb55aa,
title = "Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis",
abstract = "We examined the effect of a monoclonal antibody (mAb) against interferon (IFN)-inducible protein 10 (IP-10)/CXCL10 on the development of experimental autoimmune encephalomyelitis (EAE) in rats induced by injecting xenogeneic brain homogenates into footpads. Treatment with neutralizing mAb against CXCL10 exacerbated EAE with increased infiltrating CD4+ cells in the central nervous system. Furthermore, the exacerbation by the mAb treatment was accompanied by less enlarged draining popliteal lymph nodes (LN) in parallel with cell number compared with those of EAE rats treated with control mAb, whereas other lymphoid organs such as the spleen and thymus were not significantly different between rats treated with anti-CXCL10 and the control mAb. Induction of gene expression of CXCL9/Mig and CXCL10 and their receptor CXCR3 was confirmed in the draining LN in EAE rats. Induction of the third CXCR3 ligand, CXCL11/I-TAC was not seen in the draining LN, whereas all three CXCR3 ligands and CXCR3 itself were markedly detected in the spinal cords following the development of EAE. These findings suggest that CXCL10 produced in the LN plays a specific inhibitory role in the development of Th1-mediated diseases such as EAE by holding sensitized and activated Th1s expressing CXCR3 in the draining LN.",
keywords = "Chemokine, Experimental autoimmune encephalomyelitis, Lymph node, Spleen, Th1",
author = "Chigusa Nakajima and Takao Mukai and Nobuya Yamaguchi and Yasunari Morimoto and Park, {Woong Ryeon} and Masayuki Iwasaki and Ping Gao and Shiro Ono and Hiromi Fujiwara and Toshiyuki Hamaoka",
year = "2002",
doi = "10.1002/1521-4141(200206)32:6<1784::AID-IMMU1784>3.0.CO;2-R",
language = "English (US)",
volume = "32",
pages = "1784--1791",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "6",

}

TY - JOUR

T1 - Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis

AU - Nakajima, Chigusa

AU - Mukai, Takao

AU - Yamaguchi, Nobuya

AU - Morimoto, Yasunari

AU - Park, Woong Ryeon

AU - Iwasaki, Masayuki

AU - Gao, Ping

AU - Ono, Shiro

AU - Fujiwara, Hiromi

AU - Hamaoka, Toshiyuki

PY - 2002

Y1 - 2002

N2 - We examined the effect of a monoclonal antibody (mAb) against interferon (IFN)-inducible protein 10 (IP-10)/CXCL10 on the development of experimental autoimmune encephalomyelitis (EAE) in rats induced by injecting xenogeneic brain homogenates into footpads. Treatment with neutralizing mAb against CXCL10 exacerbated EAE with increased infiltrating CD4+ cells in the central nervous system. Furthermore, the exacerbation by the mAb treatment was accompanied by less enlarged draining popliteal lymph nodes (LN) in parallel with cell number compared with those of EAE rats treated with control mAb, whereas other lymphoid organs such as the spleen and thymus were not significantly different between rats treated with anti-CXCL10 and the control mAb. Induction of gene expression of CXCL9/Mig and CXCL10 and their receptor CXCR3 was confirmed in the draining LN in EAE rats. Induction of the third CXCR3 ligand, CXCL11/I-TAC was not seen in the draining LN, whereas all three CXCR3 ligands and CXCR3 itself were markedly detected in the spinal cords following the development of EAE. These findings suggest that CXCL10 produced in the LN plays a specific inhibitory role in the development of Th1-mediated diseases such as EAE by holding sensitized and activated Th1s expressing CXCR3 in the draining LN.

AB - We examined the effect of a monoclonal antibody (mAb) against interferon (IFN)-inducible protein 10 (IP-10)/CXCL10 on the development of experimental autoimmune encephalomyelitis (EAE) in rats induced by injecting xenogeneic brain homogenates into footpads. Treatment with neutralizing mAb against CXCL10 exacerbated EAE with increased infiltrating CD4+ cells in the central nervous system. Furthermore, the exacerbation by the mAb treatment was accompanied by less enlarged draining popliteal lymph nodes (LN) in parallel with cell number compared with those of EAE rats treated with control mAb, whereas other lymphoid organs such as the spleen and thymus were not significantly different between rats treated with anti-CXCL10 and the control mAb. Induction of gene expression of CXCL9/Mig and CXCL10 and their receptor CXCR3 was confirmed in the draining LN in EAE rats. Induction of the third CXCR3 ligand, CXCL11/I-TAC was not seen in the draining LN, whereas all three CXCR3 ligands and CXCR3 itself were markedly detected in the spinal cords following the development of EAE. These findings suggest that CXCL10 produced in the LN plays a specific inhibitory role in the development of Th1-mediated diseases such as EAE by holding sensitized and activated Th1s expressing CXCR3 in the draining LN.

KW - Chemokine

KW - Experimental autoimmune encephalomyelitis

KW - Lymph node

KW - Spleen

KW - Th1

UR - http://www.scopus.com/inward/record.url?scp=0036087256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036087256&partnerID=8YFLogxK

U2 - 10.1002/1521-4141(200206)32:6<1784::AID-IMMU1784>3.0.CO;2-R

DO - 10.1002/1521-4141(200206)32:6<1784::AID-IMMU1784>3.0.CO;2-R

M3 - Article

C2 - 12115662

AN - SCOPUS:0036087256

VL - 32

SP - 1784

EP - 1791

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 6

ER -